Who has invested in 23andMe?

Richard Branson are named among the investors backing 23andMe.

23andMe Funding: $1B Raised, IPO (2021)

23andMe funding overview

23andMe is a Biotech company based in Mountain View, California. 23andMe has raised $1B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is an IPO announced in June 2021. The round record for 23andMe runs through 2021; nothing later has been disclosed. Investors on record include Richard Branson.

23andMe at a glance

Total raised: $1B
Latest round: IPO
Latest round date: June 2021
Industry: Biotech
Headquarters: Mountain View, California
Notable investors: Richard Branson

Frequently asked about 23andMe funding

How much has 23andMe raised?: 23andMe has raised $1B in total disclosed funding across the rounds on record.
Who has invested in 23andMe?: Richard Branson are named among the investors backing 23andMe.
What was the latest 23andMe funding round?: The most recent disclosed round is an IPO, announced in June 2021.
Where is 23andMe based?: 23andMe is based in Mountain View, California.
What sector does 23andMe operate in?: 23andMe is tracked under Biotech from Mountain View, California, with $1B in disclosed funding.
When did 23andMe last raise?: The last disclosed 23andMe round closed in June 2021 at IPO.

We update the 23andMe record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Mountain View and their backers are listed below.

23andMe Funding: $1B Raised, IPO (2021)

23andMe funding overview

23andMe at a glance

Frequently asked about 23andMe funding

23andMe founders (1)

Companies related to 23andMe (40)

Browse related funding lists (3)